Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
International Journal of Oncology
Join Editorial Board Propose a Special Issue
Print ISSN: 1019-6439 Online ISSN: 1791-2423
Journal Cover
August 2012 Volume 41 Issue 2

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
August 2012 Volume 41 Issue 2

Full Size Image

Cover Legend PDF

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article

Interleukin 11 regulates endometrial cancer cell adhesion and migration via STAT3

  • Authors:
    • Virginia Lay
    • Joanne Yap
    • Stefan Sonderegger
    • Evdokia Dimitriadis
  • View Affiliations / Copyright

    Affiliations: Prince Henry's Institute of Medical Research, Clayton, VIC 3168, Australia
  • Pages: 759-764
    |
    Published online on: May 18, 2012
       https://doi.org/10.3892/ijo.2012.1486
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Endometrial carcinoma is the most common gynaecological malignancy. There is however a lack of curative therapies, especially for patients diagnosed with late stage, recurrent or aggressive disease, who have a poor prognosis. Interleukin (IL) 11 is a pleiotropic cytokine that has a role in a number of cancers including colon and breast cancer. IL11 was recently found to be upregulated in endometrial cancers, however the function of IL11 in endometrial cancer is not known. This study aimed to determine the effects of IL11 on endometrial cancer cell proliferation, adhesion and migration. Three endometrial cancer cell lines, Ishikawa, HEC-1A and AN3CA (derived from endometrial cancers grade I, II and III, respectively), were used to determine the effect of IL11 on endometrial cancer cell function. Cell proliferation and viability were assessed by BrdU and Wst-1 assays. Cell adhesion to the extracellular matrix proteins fibronectin, collagen I and IV, vitronectin and laminin was assessed. Modified boyden chambers were utilized to access IL11 action on migration and invasion, respectively. The specific effect of IL11 action on these processes was determined using a unique IL11 inhibitor. IL11 phosphorylated (p)-STAT3 protein abundance in all 3 cell lines but had no effect on pERK and pAKT abundance. Similarly, IL11 had no effect on cell proliferation and viability but increased adhesion of ANC3A cells to fibronectin while having no effect on the other extracellular matrix proteins. IL11 did not alter the adhesive properties of the Ishikawa and HEC-1A cells. In the AN3CA cells, IL11 treatment resulted in a 50% increase in migration and co-treatment with the specific IL11 inhibitor or a STAT3 inhibitor abolished the effect. This study shows a role for IL11 in endometrial cancer and suggests IL11 may be involved in endometrial cancer development and thus may be useful as a therapeutic target.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

View References

1 

Australian Institute of Health and Welfare (AIHW): Australasian Association of Cancer Registries (AACR): Cancer in Australia: an overview, 2008. Cancer series no. 46. Cat. no. CAN 42. AIHW; Canberra: 2008

2 

Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E and Vergote I: Endometrial cancer. Lancet. 366:491–505. 2005. View Article : Google Scholar : PubMed/NCBI

3 

Bokhman JV: Two pathogenetic types of endometrial carcinoma. Gynecol Oncol. 15:10–17. 1983. View Article : Google Scholar : PubMed/NCBI

4 

Tangjitgamol S, Anderson BO, See HT, et al: Management of endometrial cancer in Asia: consensus statement from the Asian Oncology Summit 2009. Lancet Oncol. 10:1119–1127. 2009. View Article : Google Scholar : PubMed/NCBI

5 

Niwa K, Tagami K, Lian Z, Onogi K, Mori H and Tamaya T: Outcome of fertility-preserving treatment in young women with endometrial carcinomas. BJOG. 112:317–320. 2005. View Article : Google Scholar : PubMed/NCBI

6 

Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G and Schaper F: Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J. 374:1–20. 2003. View Article : Google Scholar : PubMed/NCBI

7 

Dimitriadis E, Stoikos C, Tan YL and Salamonsen LA: Interleukin 11 signaling components signal transducer and activator of transcription 3 (STAT3) and suppressor of cytokine signaling 3 (SOCS3) regulate human endometrial stromal cell differentiation. Endocrinology. 147:3809–3817. 2006. View Article : Google Scholar

8 

Chen HF, Lin CY, Chao KH, Wu MY, Yang YS and Ho HN: Defective production of interleukin-11 by decidua and chorionic villi in human anembryonic pregnancy. J Clin Endocrinol Metab. 87:2320–2328. 2002. View Article : Google Scholar : PubMed/NCBI

9 

Karpovich N, Chobotova K, Carver J, Heath JK, Barlow DH and Mardon HJ: Expression and function of interleukin-11 and its receptor alpha in the human endometrium. Mol Hum Reprod. 9:75–80. 2003. View Article : Google Scholar : PubMed/NCBI

10 

von Rango U, Alfer J, Kertschanska S, et al: Interleukin-11 expression: its significance in eutopic and ectopic human implantation. Mol Hum Reprod. 10:783–792. 2004.PubMed/NCBI

11 

Paiva P, Salamonsen LA, Manuelpillai U and Dimitriadis E: Interleukin 11 inhibits human trophoblast invasion indicating a likely role in the decidual restraint of trophoblast invasion during placentation. Biol Reprod. 80:302–310. 2009. View Article : Google Scholar

12 

Paiva P, Salamonsen LA, Manuelpillai U, et al: Interleukin-11 promotes migration, but not proliferation, of human trophoblast cells, implying a role in placentation. Endocrinology. 148:5566–5572. 2007. View Article : Google Scholar : PubMed/NCBI

13 

Hanavadi S, Martin TA, Watkins G, Mansel RE and Jiang WG: Expression of interleukin 11 and its receptor and their prognostic value in human breast cancer. Ann Surg Oncol. 13:802–808. 2006. View Article : Google Scholar : PubMed/NCBI

14 

Ernst M, Najdovska M, Grail D, et al: STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest. 118:1727–1738. 2008.PubMed/NCBI

15 

Yamazumi K, Nakayama T, Kusaba T, et al: Expression of interleukin-11 and interleukin-11 receptor alpha in human colorectal adenocarcinoma; immunohistochemical analyses and correlation with clinicopathological factors. World J Gastroenterol. 12:317–321. 2006.

16 

Sales KJ, Grant V, Cook IH, et al: Interleukin-11 in endometrial adenocarcinoma is regulated by prostaglandin F2alpha-F-prostanoid receptor interaction via the calcium-calcineurin-nuclear factor of activated T cells pathway and negatively regulated by the regulator of calcineurin-1. Am J Pathol. 176:435–445. 2010. View Article : Google Scholar

17 

Yap J, Salamonsen LA, Jobling T, Nicholls PK and Dimitriadis E: Interleukin 11 is upregulated in uterine lavage and endometrial cancer cells in women with endometrial carcinoma. Reprod Biol Endocrinol. 8:632010. View Article : Google Scholar : PubMed/NCBI

18 

Lee CG, Hartl D, Matsuura H, et al: Endogenous IL-11 signaling is essential in Th2- and IL-13-induced inflammation and mucus production. Am J Resp Cell Mol Biol. 39:739–746. 2008. View Article : Google Scholar : PubMed/NCBI

19 

Menkhorst E, Salamonsen L, Robb L and Dimitriadis E: IL11 antagonist inhibits uterine stromal differentiation, causing pregnancy failure in mice. Biol Reprod. 80:920–927. 2009. View Article : Google Scholar : PubMed/NCBI

20 

Dimitriadis E, Stoikos C, Baca M, Fairlie WD, McCoubrie JE and Salamonsen LA: Relaxin and prostaglandin E(2) regulate interleukin 11 during human endometrial stromal cell decidualization. J Clin Endocrinol Metab. 90:3458–3465. 2005. View Article : Google Scholar : PubMed/NCBI

21 

Hilton DJ, Hilton AA, Raicevic A, et al: Cloning of a murine IL-11 receptor alpha-chain; requirement for gp130 for high affinity binding and signal transduction. EMBO J. 13:4765–4775. 1994.PubMed/NCBI

22 

Marwood M, Visser K, Salamonsen LA and Dimitriadis E: Interleukin-11 and leukemia inhibitory factor regulate the adhesion of endometrial epithelial cells: implications in fertility regulation. Endocrinology. 150:2915–2923. 2009. View Article : Google Scholar : PubMed/NCBI

23 

Sonderegger S, Yap J, Menkhorst E, Weston G, Stanton PG and Dimitriadis E: Interleukin (IL)11 mediates protein secretion and modification in human extravillous trophoblasts. Hum Reprod. 26:2841–2849. 2011. View Article : Google Scholar : PubMed/NCBI

24 

Painter KJ, Armstrong NJ and Sherratt JA: The impact of adhesion on cellular invasion processes in cancer and development. J Theor Biol. 264:1057–1067. 2010. View Article : Google Scholar : PubMed/NCBI

25 

Arao S, Masumoto A and Otsuki M: Beta1 integrins play an essential role in adhesion and invasion of pancreatic carcinoma cells. Pancreas. 20:129–137. 2000. View Article : Google Scholar : PubMed/NCBI

26 

Torimura T, Ueno T, Kin M, et al: Integrin alpha6beta1 plays a significant role in the attachment of hepatoma cells to laminin. J Hepatol. 31:734–740. 1999. View Article : Google Scholar : PubMed/NCBI

27 

Nakahara H, Nomizu M, Akiyama SK, Yamada Y, Yeh Y and Chen WT: A mechanism for regulation of melanoma invasion. Ligation of alpha6beta1 integrin by laminin G peptides. J Biol Chem. 271:27221–27224. 1996. View Article : Google Scholar : PubMed/NCBI

28 

Lessey BA: Integrins and the endometrium: new markers of uterine receptivity. Ann NY Acad Sci. 828:111–122. 1997. View Article : Google Scholar : PubMed/NCBI

29 

Wang J, Homer RJ, Hong L, et al: IL-11 selectively inhibits aeroallergen-induced pulmonary eosinophilia and Th2 cytokine production. J Immunol. 165:2222–2231. 2000. View Article : Google Scholar : PubMed/NCBI

30 

Luo X, Ding L and Chegini N: Gonadotropin-releasing hormone and TGF-beta activate MAP kinase and differentially regulate fibronectin expression in endometrial epithelial and stromal cells. Am J Physiol Endocrinol Metab. 287:E991–E1001. 2004. View Article : Google Scholar

31 

Jarnicki A, Putoczki T and Ernst M: Stat3: linking inflammation to epithelial cancer - more than a ‘gut’ feeling? Cell Div. 5:142010.PubMed/NCBI

32 

Seval Y, Cakmak H, Kayisli UA and Arici A: Estrogen-mediated regulation of p38 mitogen-activated protein kinase in human endometrium. J Clin Endocrinol Metab. 91:2349–2357. 2006. View Article : Google Scholar : PubMed/NCBI

33 

Futyma K, Kubiatowski T, Rozynska K, et al: Decreased osteonectin and fibronectin gene expression in endometrial cancer cancer as a prognostic marker. Ginekol Pol. 80:907–913. 2009.(In Polish).

34 

Soda H, Raymond E, Sharma S, et al: Recombinant human interleukin-11 is unlikely to stimulate the growth of the most common solid tumors. Anticancer Drugs. 10:97–101. 1999. View Article : Google Scholar : PubMed/NCBI

35 

Pignatelli M, Ansari TW, Gunter P, et al: Loss of membranous E-cadherin expression in pancreatic cancer: correlation with lymph node metastasis, high grade, and advanced stage. J Pathol. 174:243–248. 1994. View Article : Google Scholar : PubMed/NCBI

36 

Suman P, Poehlmann TG, Prakash GJ, Markert UR and Gupta SK: Interleukin-11 increases invasiveness of JEG-3 choriocarcinoma cells by modulating STAT3 expression. J Reprod Immunol. 82:1–11. 2009. View Article : Google Scholar : PubMed/NCBI

37 

Gentilini D, Busacca M, Di Francesco S, Vignali M, Vigano P and Di Blasio AM: PI3K/Akt and ERK1/2 signalling pathways are involved in endometrial cell migration induced by 17beta-estradiol and growth factors. Mol Hum Reprod. 13:317–322. 2007. View Article : Google Scholar : PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Lay V, Yap J, Sonderegger S and Dimitriadis E: Interleukin 11 regulates endometrial cancer cell adhesion and migration via STAT3. Int J Oncol 41: 759-764, 2012.
APA
Lay, V., Yap, J., Sonderegger, S., & Dimitriadis, E. (2012). Interleukin 11 regulates endometrial cancer cell adhesion and migration via STAT3. International Journal of Oncology, 41, 759-764. https://doi.org/10.3892/ijo.2012.1486
MLA
Lay, V., Yap, J., Sonderegger, S., Dimitriadis, E."Interleukin 11 regulates endometrial cancer cell adhesion and migration via STAT3". International Journal of Oncology 41.2 (2012): 759-764.
Chicago
Lay, V., Yap, J., Sonderegger, S., Dimitriadis, E."Interleukin 11 regulates endometrial cancer cell adhesion and migration via STAT3". International Journal of Oncology 41, no. 2 (2012): 759-764. https://doi.org/10.3892/ijo.2012.1486
Copy and paste a formatted citation
x
Spandidos Publications style
Lay V, Yap J, Sonderegger S and Dimitriadis E: Interleukin 11 regulates endometrial cancer cell adhesion and migration via STAT3. Int J Oncol 41: 759-764, 2012.
APA
Lay, V., Yap, J., Sonderegger, S., & Dimitriadis, E. (2012). Interleukin 11 regulates endometrial cancer cell adhesion and migration via STAT3. International Journal of Oncology, 41, 759-764. https://doi.org/10.3892/ijo.2012.1486
MLA
Lay, V., Yap, J., Sonderegger, S., Dimitriadis, E."Interleukin 11 regulates endometrial cancer cell adhesion and migration via STAT3". International Journal of Oncology 41.2 (2012): 759-764.
Chicago
Lay, V., Yap, J., Sonderegger, S., Dimitriadis, E."Interleukin 11 regulates endometrial cancer cell adhesion and migration via STAT3". International Journal of Oncology 41, no. 2 (2012): 759-764. https://doi.org/10.3892/ijo.2012.1486
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team